The prognostic value of detection of serum c-reactive protein in the patients with stage I lung cancer

Chinese Journal of Lung Cancer

Volumn 14, Issue 5, 2011, Pages 400-403

  Xu, Ye ^a   Li, Ziming ^b   Shen Tu, Yang ^b  

^a Changning District Central Hospital   (China)

^b SHANGHAI CHEST HOSPITAL   (China)

Author keywords

C reactive protein; Lung neoplasms; Operation; Prognosis; Stage I

Indexed keywords

C REACTIVE PROTEIN;

AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COMPARATIVE STUDY; FEMALE; HUMAN; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; SERUM; TUMOR VOLUME;

ADULT; AGED; C-REACTIVE PROTEIN; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR BURDEN;

EID: 79957782633     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2011.05.04     Document Type: Article

References (11)

1. Allin KH, Bojesen SE, Nordestgaard BG. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. Clin Oncol, 2009, 27(13): 2217-2224.
2. Nozoe T, Matsumata T, Kitamura M, et al. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg, 1998, 176(4): 335-338.
3. Gockel I, Dirksen K, Messow CM, et al. Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus. World J Gastroenterol, 2006, 12(23): 3746-3750.
4. Koch A, Fohlin H, Sorenson S, et al. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy. J Thorac Oncol, 2009, 4(3): 326-332.
5. Forrest LM, McMillan DC, McArdle CS, et al. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer, 2003, 89(6): 1028-1030.
6. Siemes C, Visser LE, Coebergh JW, et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: The Rotterdam Study. Clin Oncol, 2006, 24(33): 5216-5222.
7. Coussens LM, Werb Z. Inflammation and cancer. Nature, 2002, 420(6917): 860-867.
8. Kasprzyk M, Dyszkiewicz W, Zwarun D, et al. Assessment of acute phase proteins as prognostic factors in patients surgically treated for non-small cell lung cancer. Pneumonol Alergol Pol, 2008, 76(5): 321-326.
9. Caspers RJ, Pidcock NB, Cooper EH, et al. The prognostic significance of acute phase proteins in patients with inoperable squamous cell carcinoma of the bronchus. Radiother Oncol, 1984, 2(2): 107-113.
10. Kato K, Hitsuda Y, Kawasaki Y, et al. The value of serum C-reactive protein as a survival determinant in patients with advanced non-small-cell lung cancer. Nihon Kokyuki Gakkai Zasshi, 2000, 38(8): 575-580.
11. Pan JP, Zhai YC, Zhu WJ, et al. The study of the relationship with serum concentration of sICAM-1 and CRP on lung cancer. Acta Zhejiang Univ (Med), 2000, 29(4): 149-150.